I’m sharing information about the VID-19 Coronavirus crisis. Those who rely on person-to-person resources for managing mental health issues will find it very difficult to motivate themselves to get help as anxiety about the disease increases.
Close to 800,000 people die due to suicide every year. Social distancing will likely increase this rate because social distancing, while necessary, makes many people with mental health issues feel lonely, anxious, and depressed.
For cases of severe depression, Kalypso Ketamine® infusion therapy is FDA-approved as an anesthetic with a remarkably safe track record in operating rooms for surgery anesthesia and pediatric surgery. It is listed on the World Health Organization’s most Essential Medicines. Studies conducted internationally and more recently in the U.S. have shown an off-label use of ketamine to be highly effective for treatment of depression, anxiety, bipolar, PTSD, pain, inflammation, and migraines/headaches.
Unlike similar ketamine drugs, Kalypso Ketamine® comes in five proprietary formulas that are individually tailored to meet the specific needs of each patient. Kalypso Ketamine® patients have a higher success rate than similar infusion therapies.
PATIENTS SEEKING TREATMENT: (800)-RESET 20 or https://bit.ly/2UEGHij
Thank you,
Glenda, Charlie and David Cates
